Position in MYGN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$4,996,818
-$450,858 QoQ
Shares Held
1,110,404
+25.4% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $884,299,888 across 26 Diagnostics & Research names. MYGN ranks #22 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,302,097 | $246,877,590 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
418,065 | $205,491,489 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
93,297 | $52,422,651 | |
| 4 | ICLR |
Icon PLC
|
399,290 | $44,185,430 | |
| 5 | WAT |
Waters Corp /De/
|
125,534 | $37,384,025 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
216,774 | $36,968,636 | |
| 7 | A |
Agilent Technologies, Inc.
|
297,746 | $33,937,088 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
21,067 | $26,569,700 |
All Filings in MYGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,996,818 | 1,110,404 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $5,447,676 | 885,801 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $4,620,353 | 639,053 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,219,138 | 229,593 | Shares | Defined | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||